封面
市场调查报告书
商品编码
1619023

全球 NGS 样品製备市场规模、份额和成长分析:按产品和服务、按工作流程、按样品类型、按方法、按应用、按最终用户、按地区 - 行业预测 (2024-2031)

NGS Sample Preparation Market Size, Share, Growth Analysis, By Products & Services, By Workflow, By Sample Type, By Method, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球NGS样本製备市场规模为25亿美元,从2023年的29亿美元成长到2031年的85亿美元,预计复合年增长率为14.4%。

全球次世代定序仪(NGS) 样本製备市场正经历强劲成长,预计未来几年将持续成长。该领域专注于利用奈米技术进行 DNA 和 RNA 样品製备,以促进高通量定序,从而产生重要的遗传见解。定序资料的准确性和品质高度依赖有效的 NGS 样品製备,从而推动需求。奈米技术的最新进展引入了奈米磁珠、奈米流体和微流体等创新技术,以优化样品处理并提高效率。这些创新将缩短交付时间和成本,使研究人员和临床医生更容易获得它们,并将增强未来的基因研究和应用。

目录

介绍

  • 研究目的
  • 调查范围
  • 定义

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 抑制因素和挑战
  • 波特的分析和影响
    • 竞争公司之间的敌对关係
    • 替代品的威胁
    • 买方议价能力
    • 新进入者的威胁
    • 供应商的议价能力

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 技术进步
  • 监管环境
  • 专利分析
  • 价值链分析
  • 客户和购买标准分析
  • PESTEL分析
  • 总体经济指标
  • 市场吸引力指数
  • 价格分析

NGS 样品製备市场规模:依产品/服务划分,复合年增长率 (2024-2031)

  • 市场概况
  • 工作站/设备
  • 试剂/耗材
  • 服务

NGS 样品製备市场规模:依工作流程划分,复合年增长率(2024-2031)

  • 市场概况
  • DNA 片段化与文库製备
  • 靶向序列捕获
  • 品管

NGS 样品製备市场规模:依样品类型,复合年增长率(2024-2031)

  • 市场概况
  • DNA
  • RNA

NGS 样品製备市场规模:依方法划分,复合年增长率(2024-2031)

  • 市场概况
  • 手动样品製备
  • 微流体样品製备
  • 基于自动化液体处理的样品製备

NGS 样品製备市场规模:依应用划分,复合年增长率(2024-2031)

  • 市场概况
  • 疾病诊断
    • 癌症诊断
    • 生殖健康检查
    • 感染疾病诊断
    • 其他的
  • 药物发现
  • 农业和动物研究
  • 其他的

NGS 样品製备市场规模:依最终用户划分,复合年增长率(2024-2031)

  • 市场概况
  • 医院/诊所
  • 学术机构/研究中心
  • 製药和生物技术公司
  • 其他的

NGS 样品製备市场规模,复合年增长率(2024-2031)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中东/非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲

竞争资讯

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2023)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分類的份额分析
    • 收益与前一年同期比较(2021-2023)

主要企业简介

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Revvity Inc.
  • Agilent Technologies, Inc.
  • Danaher
  • Becton, Dickinson and Company
  • Qiagen
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Promega Corporation
  • Eurofins Scientific
  • BGI Group
  • 10x Genomics
  • Sysmex Corporation
  • Psomagen
  • Zymo Research Corporation
  • Takara Holdings Inc
  • Nanjing Novogene Bio Technology Co., Ltd.
  • New England Biolabs

结论和建议

简介目录
Product Code: SQMIG35D2097

Global NGS Sample Preparation Market size was valued at USD 2.5 billion in 2022 and is poised to grow from USD 2.9 billion in 2023 to USD 8.5 billion by 2031, growing at a CAGR of 14.4% during the forecast period (2024-2031).

The global Next-Generation Sequencing (NGS) sample preparation market is experiencing robust growth, expected to persist in the coming years. This segment focuses on DNA and RNA sample preparation utilizing nanoscale technologies, facilitating high-throughput sequencing that delivers critical genetic insights. The accuracy and quality of sequencing data heavily depend on effective NGS sample preparation, consequently fueling demand. Recent advancements in nanotechnology have led to the emergence of innovative techniques, such as nano-sized magnetic beads, nanofluidics, and microfluidics, which optimize sample processing for greater efficiency. These innovations reduce both turnaround time and costs, making NGS sample preparation more accessible to researchers and clinicians alike, and paving the way for enhanced genetic research and applications going forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ngs Sample Preparation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ngs Sample Preparation Market Segmental Analysis

Global NGS Sample Preparation Market is segmented by Products & Services, Workflow, Sample Type, Method, Application, End User and Region. Based on Products & Services, the market is segmented into Workstations/Instruments, Reagents & Consumables, Services. Based on Workflow, the market is segmented into DNA Fragmentation & Library Preparation, Target Enrichment, Quality Control. Based on Sample Type, the market is segmented into DNA, RNA. Based on Method, the market is segmented into Manual Sample Preparation, Microfluidic Sample Preparation, Automated Liquid Handling-based Sample Preparation. Based on Application, the market is segmented into Disease Diagnostics (Cancer Diagnostics, Reproductive Health Diagnostics, Infectious Disease Diagnostics, Others), Drug Discovery, Agricultural & Animal Research, Others. Based on End User, the market is segmented into Hospitals & Clinics, Academic Institutes & Research Centers, Pharma & Biotech Companies, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ngs Sample Preparation Market

The Global NGS Sample Preparation market is being propelled by the increasing applications within genomic research, which encompass gene expression analysis, variant detection, biomarker discovery, and metagenomics. As genomic studies advance and diversify, there is a rising need for effective and high-throughput sample preparation techniques for next-generation sequencing (NGS). This heightened demand signifies that researchers require innovative methodologies to efficiently process samples, ultimately fostering significant growth in the market. The integration of emerging technologies and improved protocols further amplifies this trend, establishing NGS sample preparation as a pivotal component in the progression of genomic research and its related applications.

Restraints in the Global Ngs Sample Preparation Market

The Global NGS Sample Preparation market faces significant restraints due to challenges associated with data analysis and storage. As Next-Generation Sequencing (NGS) produces vast amounts of data, it requires advanced bioinformatics tools and substantial storage capacity. These extensive genomic datasets pose management difficulties, necessitating skilled bioinformaticians, robust technological infrastructure, and secure storage solutions. Such complexities can hinder the broader adoption and effective implementation of NGS sample preparation techniques. The need for specialized expertise and reliable systems to handle and analyze this wealth of information often complicates efforts to fully leverage the potential of NGS technology in various applications.

Market Trends of the Global Ngs Sample Preparation Market

As of October 2023, the global Next-Generation Sequencing (NGS) sample preparation market is witnessing a notable trend towards automation and high-throughput solutions. The escalating volume of samples required for NGS applications has spurred the demand for efficient, streamlined processes that minimize human error and labor. Automated sample preparation systems are rapidly gaining traction due to their ability to enhance accuracy, improve reproducibility, and significantly increase throughput. By leveraging advanced robotics and sophisticated liquid handling techniques, these systems effectively automate critical steps such as DNA/RNA extraction, library preparation, and target enrichment, propelling the market towards more efficient genomic workflows and reducing turnaround times.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • Customer & Buying Criteria Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Market Attractiveness Index
  • Pricing Analysis

Global NGS Sample Preparation Market Size by Products & Services & CAGR (2024-2031)

  • Market Overview
  • Workstations/Instruments
  • Reagents & Consumables
  • Services

Global NGS Sample Preparation Market Size by Workflow & CAGR (2024-2031)

  • Market Overview
  • DNA Fragmentation & Library Preparation
  • Target Enrichment
  • Quality Control

Global NGS Sample Preparation Market Size by Sample Type & CAGR (2024-2031)

  • Market Overview
  • DNA
  • RNA

Global NGS Sample Preparation Market Size by Method & CAGR (2024-2031)

  • Market Overview
  • Manual Sample Preparation
  • Microfluidic Sample Preparation
  • Automated Liquid Handling-based Sample Preparation

Global NGS Sample Preparation Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Disease Diagnostics
    • Cancer Diagnostics
    • Reproductive Health Diagnostics
    • Infectious Disease Diagnostics
    • Others
  • Drug Discovery
  • Agricultural & Animal Research
  • Others

Global NGS Sample Preparation Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Hospitals & Clinics
  • Academic Institutes & Research Centers
  • Pharma & Biotech Companies
  • Others

Global NGS Sample Preparation Market Size & CAGR (2024-2031)

  • North America (Products & Services, Workflow, Sample Type, Method, Application, End User)
    • US
    • Canada
  • Europe (Products & Services, Workflow, Sample Type, Method, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Products & Services, Workflow, Sample Type, Method, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Products & Services, Workflow, Sample Type, Method, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Products & Services, Workflow, Sample Type, Method, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Illumina, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 10x Genomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Psomagen
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymo Research Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Holdings Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nanjing Novogene Bio Technology Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New England Biolabs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation